Livzon Pharmaceutical : POLL RESULTS OF THE 2019 FOURTH EXTRAORDINARY GENERAL MEETING HELD ON MONDAY, 9 DECEMBER 2019

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

POLL RESULTS OF

THE 2019 FOURTH EXTRAORDINARY GENERAL MEETING

HELD ON MONDAY, 9 DECEMBER 2019

Reference is made to the notice of the 2019 Fourth Extraordinary General Meeting (the "EGM") of 麗珠醫藥集團 股份有限公司 Livzon Pharmaceutical Group Inc.＊(the "Company") dated 23 October 2019 and the circular of the Company dated 15 November 2019 (the "Circular"). Unless otherwise defined, capitalised terms used in this announcement shall have the same meanings as those defined in the Circular.

The Board is pleased to announce that the proposed resolution as set out in the notice of the EGM was duly passed by way of poll at the EGM held on 9 December 2019.

As at the date of the EGM, there were 934,762,675 shares of the Company (the "Shares") (comprising 614,898,458 A Shares and 319,864,217 H Shares) in issue. Therefore, Shareholders of 934,762,675 Shares (or authorized proxies) were entitled to attend and vote on the resolution proposed at the EGM.

To the best of the Directors' knowledge, information and belief and having made all reasonable enquiries, there were no restrictions on any Shareholders for casting votes on the resolution proposed at the EGM and none of the Shareholders have stated their intention in the Circular to vote against or to abstain from voting on any of the resolution at the EGM.

1

ATTENDANCE OF THE EGM

Set out below are the details of the Shareholders and authorized proxies present at the EGM:

Number of Shareholders and authorized proxies

Including: Number of A Shareholders and authorized proxies

Number of H Shareholders and authorized proxies

Total number of Shares carrying voting rights (Shares)

Including: Total number of A Shares carrying voting rights held by A Shareholders and authorized proxies (shares)

Total number of H Shares carrying voting rights held by H

Shareholders and authorized proxies (shares)

15

14

1

465,508,829

249,112,467

216,396,362

Percentage of the total number of Shares carrying voting rights (%)	49.80%
Including: Total number of Shares carrying voting rights held by A Shareholders and authorized	26.65%
proxies as a percentage of the total number of Shares carrying voting rights (%)
Total number of Shares carrying voting rights held by H Shareholders and authorized	23.15%
proxies as a percentage of the total number of Shares carrying voting rights (%)

2

POLL RESULTS OF THE EGM

For

Against

Abstain

Number of

Approximate

Approximate

Approximate

percentage (%)

percentage (%)

percentage (%)

Shares with

of total number

of total number

of total number

No.

Resolution#

Category of

voting rights held

of Shares with

Number of

of Shares with

Number of

of Shares with

Shares

by Shareholders

Number of Shares

voting rights

Shares

voting rights

Shares

voting rights

present at the

held by

held by

held by

EGM

Shareholders

Shareholders

Shareholders

present at the

present at the

present at the

EGM

EGM

EGM

Ordinary Resolution

Total

465,508,829

463,728,390

99.6175%

308,839

0.0663%

1,471,600

0.3161%

To consider and approve the

1

change

of the auditor of the

Company for the year 2019 and

A Shares

249,112,467

249,096,878

99.9937%

15,589

0.0063%

0

0.0000%

fix its remuneration.

H Shares

216,396,362

214,631,512

99.1844%

293,250

0.1355%

1,471,600

0.6800%

As votes cast in favour of the above ordinary resolution were more than one-half of the valid voting rights of Shareholders (including authorized proxies) present at the EGM, the

above ordinary resolution was duly passed as an ordinary resolution.

3

Ruihua Certified Public Accountants (LLP) (瑞華會計師事務所(特殊普通合夥)), the auditors of the Company, acted as the scrutineer for the vote-taking at the EGM. The Company's PRC legal advisors, D&S Law Firm (廣東德 賽律師事務所), two Shareholders' representatives and a representative of supervisors of the Company also jointly acted as the scrutineers for the vote-taking of the poll at the EGM.

LEGAL OPINION ISSUED BY LAWYERS

Delegated lawyers from D&S Law Firm witnessed the EGM and issued the "Legal Opinions of D&S Law Firm on the EGM of Livzon Pharmaceutical Group Inc. (《 廣東德賽律師事務所關於麗珠醫藥集團股份有限公司二零 一九年第四次臨時股東大會的法律意見書》 )", certifying that: "The convening and procedures comply with the requirements of laws, regulations and Articles of Association of the Company; the qualifications of personnels who attended the EGM, the qualifications of the conveners, and the voting procedure of the EGM are legal and effective; the voting results of the resolution at the EGM, are legal and effective. "

SPECIAL NOTICE

There was neither objection to the proposed resolution of the EGM, nor changes to the resolutions of the previous general meetings at the EGM.

By order of the Board

麗珠醫藥集團股份有限公司

Livzon Pharmaceutical Group Inc. *

Yang Liang

Company Secretary

Zhuhai, China

9 December 2019

As at the date of this announcement, the Executive Directors of the Company are Mr. Tang Yanggang (President) and Mr. Xu Guoxiang (Vice Chairman and Vice President); the Non-Executive Directors of the Company are Mr. Zhu Baoguo (Chairman), Mr. Tao Desheng (Vice Chairman) and Mr. Qiu Qingfeng; and the Independent Non-Executive Directors of the Company are Mr. Xu Yanjun, Mr. Zheng Zhihua, Mr. Xie Yun, Mr. Tian Qiusheng and Mr. Wong Kam Wa.

* For identification purpose only

4